Qlucore elects new chairman and board member
Also expands marketing and development team
Charlotte Edenius, who has extensive experience with pharmaceutical companies such as AstraZeneca and Orexo, has joined the board.
The company has also added two more staff to its marketing and development teams to help meet demand for Qlucore Omics Explorer software.
Qlucore, based in Lund, develops software which analyses data and visualises complicated structures in 3D directly on a computer screen.
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Regulatory
Data tool helps research on in vitro allergen testing
New research techniques using data analysis tools are helping to reduce the reliance on animal testing for the identification of skin sensitising chemicals that elicit an adverse immune response in humans. A novel cell-based assay called Genomic Allergen Rapid Detection (GARD) for the prediction of sensitising chemicals identifies markers that are involved in biological pathways with immunological relevant functions.
Research & Development
Data visualisation with the image makers
Genetic research and modern drug discovery techniques create masses of data for researchers to trawl through to find that all important scientific breakthrough. Qlucore is helping scientists see those potential ‘eureka’ moments more clearly
Digital
TXP secures £1.5m MHRA contract for cloud architecture and cyber security services
The deal extends TXP's existing MHRA partnership, supporting the regulatory agency's digital modernisation through infrastructure development and knowledge transfer as TXP expands its UK public sector footprint
Digital
Camgenium launches pre-certified Foundation Platform for connected medical device development
The infrastructure combines IEC 62304-compliant firmware, ISO 27001 cloud hosting and automated regulatory reporting, letting OEM teams focus engineering effort on clinical differentiation rather than compliance build-out